Dr. Rajeev Saggar - 13 Mar 2026 Form 4 Insider Report for Liquidia Corp (LQDA)

Role: Chief Medical Officer
Signature: /s/ Dr. Rajeev Saggar
Issuer symbol: LQDA
Transactions as of: 13 Mar 2026
Net transactions value: -$1,283,834
Form type: 4
Filing time: 17 Mar 2026, 16:31:24 UTC
Previous filing: 21 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Saggar Rajeev	Chief Medical Officer	419 DAVIS DRIVE, SUITE 100, MORRISVILLE	/s/ Dr. Rajeev Saggar	17 Mar 2026	0001935638

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LQDA	Common Stock	Sale	$1,283,834	-35,365	-17%	$36.30	174,473	13 Mar 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $36.29 to $36.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	Includes (i) 20,833 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 28,246 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 53,835 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,213 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.

Content

Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $36.29 to $36.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes (i) 20,833 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 28,246 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 53,835 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,213 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.